Segall Bryant & Hamill LLC Sells 539 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Segall Bryant & Hamill LLC lessened its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 0.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 301,670 shares of the company’s stock after selling 539 shares during the period. Segall Bryant & Hamill LLC owned 0.18% of Option Care Health worth $9,442,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the business. Avior Wealth Management LLC lifted its stake in shares of Option Care Health by 11.2% in the third quarter. Avior Wealth Management LLC now owns 24,300 shares of the company’s stock worth $761,000 after acquiring an additional 2,442 shares during the period. Pathstone Holdings LLC boosted its stake in shares of Option Care Health by 9.8% in the 3rd quarter. Pathstone Holdings LLC now owns 68,895 shares of the company’s stock valued at $2,156,000 after purchasing an additional 6,134 shares during the last quarter. Lindenwold Advisors INC increased its position in shares of Option Care Health by 5.4% during the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock worth $299,000 after buying an additional 489 shares during the period. Thrivent Financial for Lutherans raised its stake in Option Care Health by 7.4% during the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock worth $183,541,000 after buying an additional 404,811 shares during the last quarter. Finally, Natixis Advisors LLC lifted its holdings in Option Care Health by 9.3% in the third quarter. Natixis Advisors LLC now owns 88,751 shares of the company’s stock valued at $2,778,000 after buying an additional 7,529 shares during the period. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Performance

NASDAQ OPCH opened at $22.46 on Friday. The company has a market cap of $3.82 billion, a P/E ratio of 18.87, a PEG ratio of 2.26 and a beta of 1.32. The company has a fifty day simple moving average of $27.80 and a 200 day simple moving average of $29.16. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.63.

Analysts Set New Price Targets

A number of analysts have weighed in on OPCH shares. Barrington Research decreased their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. JMP Securities lifted their target price on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and cut their price target for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Finally, Truist Financial cut their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $30.83.

Insider Transactions at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.64% of the stock is currently owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.